Russia to begin Phase III trials of second COVID-19 vaccine
Moscow Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Friday. Early-stage clinical trials fo
